ES2547415T3 - Derivados de oxiindol con actividad agonista del receptor de motilina - Google Patents
Derivados de oxiindol con actividad agonista del receptor de motilina Download PDFInfo
- Publication number
- ES2547415T3 ES2547415T3 ES10746028.9T ES10746028T ES2547415T3 ES 2547415 T3 ES2547415 T3 ES 2547415T3 ES 10746028 T ES10746028 T ES 10746028T ES 2547415 T3 ES2547415 T3 ES 2547415T3
- Authority
- ES
- Spain
- Prior art keywords
- piperidin
- dimethyl
- oxoindolin
- oxo
- phenylbutan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20243009P | 2009-02-27 | 2009-02-27 | |
| US202430P | 2009-02-27 | ||
| US28217309P | 2009-12-24 | 2009-12-24 | |
| US282173P | 2009-12-24 | ||
| PCT/JP2010/001368 WO2010098145A1 (en) | 2009-02-27 | 2010-03-01 | Oxyindole derivatives with motilin receptor agonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2547415T3 true ES2547415T3 (es) | 2015-10-06 |
Family
ID=42665356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10746028.9T Active ES2547415T3 (es) | 2009-02-27 | 2010-03-01 | Derivados de oxiindol con actividad agonista del receptor de motilina |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8697877B2 (enExample) |
| EP (1) | EP2401268B1 (enExample) |
| JP (1) | JP5663743B2 (enExample) |
| KR (1) | KR101575703B1 (enExample) |
| CN (1) | CN102317280B (enExample) |
| BR (1) | BRPI1007962A2 (enExample) |
| CA (1) | CA2750699C (enExample) |
| ES (1) | ES2547415T3 (enExample) |
| MX (1) | MX2011008857A (enExample) |
| RU (1) | RU2533116C2 (enExample) |
| WO (1) | WO2010098145A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013369649B2 (en) * | 2012-12-31 | 2018-07-26 | Sunovion Pharmaceuticals Inc. | Heterocyclic compounds and methods of use thereof |
| CN105849102B (zh) * | 2013-10-29 | 2020-10-16 | 生物马林药物股份有限公司 | 作为葡萄糖基神经酰胺合酶抑制剂的n-(1-羟基-3(吡咯烷基)丙烷-2-基)吡咯烷-3-甲酰胺衍生物 |
| JP6836502B2 (ja) * | 2014-05-30 | 2021-03-03 | スプハエラ ファーマ ピーヴィーティー リミテッド | 抗結核薬としての新規な化合物 |
| KR20240042400A (ko) * | 2021-07-30 | 2024-04-02 | 라퀄리아 파마 인코포레이티드 | 결정질 형태 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW355711B (en) | 1992-11-04 | 1999-04-11 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives |
| JP3449766B2 (ja) | 1993-11-19 | 2003-09-22 | 中外製薬株式会社 | モチリンアンタゴニスト |
| US5767118A (en) * | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
| JP3901239B2 (ja) | 1996-03-13 | 2007-04-04 | 大正製薬株式会社 | アリールアルカン誘導体 |
| US5734012A (en) | 1996-05-16 | 1998-03-31 | Ohmeda Pharmaceutical Products Division Inc. | Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
| DE19644195A1 (de) | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| AU4968997A (en) | 1996-11-26 | 1998-06-22 | Chugai Seiyaku Kabushiki Kaisha | 13-membered ring macrolide compounds, medicine containing the same, and process for producing the same |
| TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| US5972939A (en) | 1997-10-28 | 1999-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclopentene derivatives useful as antagonists of the motilin receptor |
| DE19805822B4 (de) | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6165985A (en) | 1998-02-13 | 2000-12-26 | Solvay Pharmaceuticals Gmbh | 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| AU2001247357A1 (en) | 2000-03-13 | 2001-09-24 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclobutene derivatives useful as antagonists of the motilin receptor |
| US6392040B2 (en) | 2000-03-13 | 2002-05-21 | Ortho-Mcneil Pharmaceutical, Inc. | Cyclopentene compounds useful as antagonists of the motilin receptor |
| AU2001250820A1 (en) | 2000-03-13 | 2001-09-24 | Ortho-Mcneil Pharmaceutical, Inc. | Novel cyclohexene derivatives useful as antagonists of the motilin receptor |
| US6511980B2 (en) | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| DE50204789D1 (de) * | 2001-05-10 | 2005-12-08 | Solvay Pharm Gmbh | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE602004030344D1 (de) | 2003-07-31 | 2011-01-13 | Tranzyme Pharma Inc | Räumlich definierte makrocyclische verbindungen, die sich für die entdeckung von arzneimittel eignen |
| WO2005012332A1 (en) | 2003-07-31 | 2005-02-10 | Tranzyme Pharma | Spatially-defined macrocycles incorporating peptide bond surrogates |
| US7338954B2 (en) | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| US7262195B2 (en) | 2003-09-17 | 2007-08-28 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| WO2006011035A1 (en) | 2004-07-23 | 2006-02-02 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
| NZ556627A (en) * | 2005-02-22 | 2010-09-30 | Pfizer | Oxyindole derivatives as 5HT4 receptor agonists |
| US7582611B2 (en) | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
| EP1902022A1 (en) | 2005-07-12 | 2008-03-26 | Glaxo Group Limited | Piperazine heteroaryl derivates as gpr38 agonists |
| MY150098A (en) | 2005-07-26 | 2013-11-29 | Glaxo Group Ltd | Benzylpiperazine derivates and their medical use |
| EP1757290A1 (en) * | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| PL2041093T3 (pl) * | 2006-06-28 | 2010-09-30 | Glaxo Group Ltd | Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38 |
-
2010
- 2010-03-01 EP EP10746028.9A patent/EP2401268B1/en active Active
- 2010-03-01 JP JP2011536661A patent/JP5663743B2/ja active Active
- 2010-03-01 CN CN201080007432.5A patent/CN102317280B/zh active Active
- 2010-03-01 RU RU2011139287/04A patent/RU2533116C2/ru active IP Right Revival
- 2010-03-01 MX MX2011008857A patent/MX2011008857A/es active IP Right Grant
- 2010-03-01 WO PCT/JP2010/001368 patent/WO2010098145A1/en not_active Ceased
- 2010-03-01 KR KR1020117021833A patent/KR101575703B1/ko active Active
- 2010-03-01 CA CA2750699A patent/CA2750699C/en not_active Expired - Fee Related
- 2010-03-01 ES ES10746028.9T patent/ES2547415T3/es active Active
- 2010-03-01 BR BRPI1007962A patent/BRPI1007962A2/pt not_active IP Right Cessation
- 2010-03-01 US US13/203,301 patent/US8697877B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2401268A1 (en) | 2012-01-04 |
| US8697877B2 (en) | 2014-04-15 |
| CN102317280B (zh) | 2014-07-23 |
| JP5663743B2 (ja) | 2015-02-04 |
| CA2750699C (en) | 2015-12-29 |
| RU2533116C2 (ru) | 2014-11-20 |
| CN102317280A (zh) | 2012-01-11 |
| EP2401268B1 (en) | 2015-07-29 |
| EP2401268A4 (en) | 2013-01-02 |
| KR20110133033A (ko) | 2011-12-09 |
| KR101575703B1 (ko) | 2015-12-10 |
| MX2011008857A (es) | 2011-09-30 |
| BRPI1007962A2 (pt) | 2016-02-23 |
| WO2010098145A1 (en) | 2010-09-02 |
| HK1164318A1 (en) | 2012-09-21 |
| RU2011139287A (ru) | 2013-04-10 |
| US20110312933A1 (en) | 2011-12-22 |
| JP2012519153A (ja) | 2012-08-23 |
| CA2750699A1 (en) | 2010-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019204244B2 (en) | Cyclopropylamines as lsd1 inhibitors | |
| ES2586213T3 (es) | Compuestos de bencenosulfonamida y su uso como agentes terapéuticos | |
| ES2748402T3 (es) | Derivado de 2-acilaminotiazol y sal del mismo | |
| WO2010087399A1 (ja) | ウロテンシンｉｉ受容体拮抗薬 | |
| ES2431824T3 (es) | Compuesto cíclico que tiene heteroátomo | |
| PT1499589E (pt) | Derivados de n- fenil ( piperidin-2-il ) metilbenzamida, sua preparação e sua aplicação em terapêutica | |
| ES2648512T3 (es) | Derivados de carbamato/urea | |
| BRPI0711740A2 (pt) | compostos, processo para a sua manufatura,composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, método para o tratamento ou prevenção de obesidade, de diabetes do tipo ii, e uso dos compostos na manufatura de medicamentos | |
| ES3047718T3 (en) | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | |
| WO2013147160A1 (ja) | 環状アミン誘導体及びその医薬用途 | |
| US20240239744A1 (en) | 2-(3-ethynylbenzyl)-substituted heterocycle derivatives and related uses | |
| ES2719626T3 (es) | Moduladores alostéricos positivos al receptor M1 muscarínico | |
| ITTO960718A1 (it) | Nuovi derivati di piperidina, procedimento per il loro ottenimento e composizioni farmaceutiche che li contengono | |
| CA2852173A1 (en) | Macrocyclic amides as protease inhibitors | |
| EA038286B1 (ru) | Соединения алкилдигидрохинолинсульфонамида | |
| RU2533116C2 (ru) | Оксииндольные производные, обладающие агонистической активностью в отношении мотилинового рецептора | |
| US20120122950A1 (en) | Libraries of 1-(sulfonyl)-n-phenylpyrrolidine-2-carboxamides for drug discovery | |
| US20120129888A1 (en) | Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for drug discovery | |
| ES2753227T3 (es) | Derivado de piperazina | |
| JP2012519153A5 (enExample) | ||
| ES2478042T3 (es) | Derivado de amida y composición farmacéutica que contiene el mismo | |
| ES2244243T3 (es) | Deerivados de quinazolinona. | |
| ES2880174T3 (es) | Derivado de piperazina | |
| ES2834009T3 (es) | Moduladores heteroaromáticos del receptor gamma huérfano relacionado con retinoides | |
| BR112020001588A2 (pt) | agente terapêutico ou um agente preventivo para alopecia areata |